Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study
The objective of this cross-sectional study was to assess differences in the control and treatment of modifiable cardiovascular risk factors (CVRF: HbA1c, blood pressure [BP], LDL-cholesterol, body mass index, and smoking habit) according to gender and the presence of cardiovascular disease (CVD) in...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2014/131709 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849693802364665856 |
|---|---|
| author | Josep Franch-Nadal Manel Mata-Cases Irene Vinagre Flor Patitucci Eduard Hermosilla Aina Casellas Bonaventura Bolivar Dídac Mauricio |
| author_facet | Josep Franch-Nadal Manel Mata-Cases Irene Vinagre Flor Patitucci Eduard Hermosilla Aina Casellas Bonaventura Bolivar Dídac Mauricio |
| author_sort | Josep Franch-Nadal |
| collection | DOAJ |
| description | The objective of this cross-sectional study was to assess differences in the control and treatment of modifiable cardiovascular risk factors (CVRF: HbA1c, blood pressure [BP], LDL-cholesterol, body mass index, and smoking habit) according to gender and the presence of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) in Catalonia, Spain. The study included available data from electronic medical records for a total of 286,791 patients. After controlling for sex, age, diabetes duration, and treatment received, both men and women with prior CVD had worse cardiometabolic control than patients without previous CVD; women with prior CVD had worse overall control of CVRFs than men except for smoking; and women without prior CVD were only better than men at controlling smoking and BP, with no significant differences in glycemic control. Finally, although the proportion of women treated with lipid-lowering medications was similar to (with prior CVD) or even higher (without CVD) than men, LDL-cholesterol levels were remarkably uncontrolled in both women with and women without CVD. The results stress the need to implement measures to better prevent and treat CVRF in the subgroup of diabetic women, specifically with more intensive statin treatment in those with CVD. |
| format | Article |
| id | doaj-art-4f25839a29b547ffb997794fa4b50e11 |
| institution | DOAJ |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-4f25839a29b547ffb997794fa4b50e112025-08-20T03:20:17ZengWileyInternational Journal of Endocrinology1687-83371687-83452014-01-01201410.1155/2014/131709131709Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl StudyJosep Franch-Nadal0Manel Mata-Cases1Irene Vinagre2Flor Patitucci3Eduard Hermosilla4Aina Casellas5Bonaventura Bolivar6Dídac Mauricio7Primary Health Care Center Raval, Gerència d’Àmbit d’Atenció Primària Barcelona Ciutat, Institut Catala de la Salut, Avenida Drassanes 17-21, 08001 Barcelona, SpainUnitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari de Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Avenida Gran Via de les Corts Catalanes, 587 Àtic, 08007 Barcelona, SpainDepartment of Endocrinology and Nutrition, Diabetes Unit, Hospital Clinic, University of Barcelona, C/Villarroel 170, 08036 Barcelona, SpainPrimary Health Care Center Raval, Gerència d’Àmbit d’Atenció Primària Barcelona Ciutat, Institut Catala de la Salut, Avenida Drassanes 17-21, 08001 Barcelona, SpainUnitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari de Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Avenida Gran Via de les Corts Catalanes, 587 Àtic, 08007 Barcelona, SpainUnitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari de Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Avenida Gran Via de les Corts Catalanes, 587 Àtic, 08007 Barcelona, SpainUnitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari de Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Avenida Gran Via de les Corts Catalanes, 587 Àtic, 08007 Barcelona, SpainUnitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari de Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Avenida Gran Via de les Corts Catalanes, 587 Àtic, 08007 Barcelona, SpainThe objective of this cross-sectional study was to assess differences in the control and treatment of modifiable cardiovascular risk factors (CVRF: HbA1c, blood pressure [BP], LDL-cholesterol, body mass index, and smoking habit) according to gender and the presence of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) in Catalonia, Spain. The study included available data from electronic medical records for a total of 286,791 patients. After controlling for sex, age, diabetes duration, and treatment received, both men and women with prior CVD had worse cardiometabolic control than patients without previous CVD; women with prior CVD had worse overall control of CVRFs than men except for smoking; and women without prior CVD were only better than men at controlling smoking and BP, with no significant differences in glycemic control. Finally, although the proportion of women treated with lipid-lowering medications was similar to (with prior CVD) or even higher (without CVD) than men, LDL-cholesterol levels were remarkably uncontrolled in both women with and women without CVD. The results stress the need to implement measures to better prevent and treat CVRF in the subgroup of diabetic women, specifically with more intensive statin treatment in those with CVD.http://dx.doi.org/10.1155/2014/131709 |
| spellingShingle | Josep Franch-Nadal Manel Mata-Cases Irene Vinagre Flor Patitucci Eduard Hermosilla Aina Casellas Bonaventura Bolivar Dídac Mauricio Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study International Journal of Endocrinology |
| title | Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study |
| title_full | Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study |
| title_fullStr | Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study |
| title_full_unstemmed | Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study |
| title_short | Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study |
| title_sort | differences in the cardiometabolic control in type 2 diabetes according to gender and the presence of cardiovascular disease results from the econtrol study |
| url | http://dx.doi.org/10.1155/2014/131709 |
| work_keys_str_mv | AT josepfranchnadal differencesinthecardiometaboliccontrolintype2diabetesaccordingtogenderandthepresenceofcardiovasculardiseaseresultsfromtheecontrolstudy AT manelmatacases differencesinthecardiometaboliccontrolintype2diabetesaccordingtogenderandthepresenceofcardiovasculardiseaseresultsfromtheecontrolstudy AT irenevinagre differencesinthecardiometaboliccontrolintype2diabetesaccordingtogenderandthepresenceofcardiovasculardiseaseresultsfromtheecontrolstudy AT florpatitucci differencesinthecardiometaboliccontrolintype2diabetesaccordingtogenderandthepresenceofcardiovasculardiseaseresultsfromtheecontrolstudy AT eduardhermosilla differencesinthecardiometaboliccontrolintype2diabetesaccordingtogenderandthepresenceofcardiovasculardiseaseresultsfromtheecontrolstudy AT ainacasellas differencesinthecardiometaboliccontrolintype2diabetesaccordingtogenderandthepresenceofcardiovasculardiseaseresultsfromtheecontrolstudy AT bonaventurabolivar differencesinthecardiometaboliccontrolintype2diabetesaccordingtogenderandthepresenceofcardiovasculardiseaseresultsfromtheecontrolstudy AT didacmauricio differencesinthecardiometaboliccontrolintype2diabetesaccordingtogenderandthepresenceofcardiovasculardiseaseresultsfromtheecontrolstudy |